2-Amino-4,5-bis(2-methoxyethoxy)benzonitrile
- CAS No.950596-58-4
- GradeIndustrial / Pharmaceutical
- Availability● In Stock
High-purity pharmaceutical intermediate for Erlotinib synthesis. Available in bulk with full COA documentation.
Request Bulk PricingProduct Technical Details
Product Overview
2-Amino-4,5-bis(2-methoxyethoxy)benzonitrile is a specialized organic compound primarily utilized as a critical building block in the pharmaceutical industry. With the CAS registry number 950596-58-4, this substance serves as a key intermediate in the multi-step synthesis of Erlotinib, a well-known tyrosine kinase inhibitor used in oncology treatments. Our manufacturing process ensures that every batch meets stringent quality standards required for active pharmaceutical ingredient (API) production.
As a leading supplier in the fine chemicals sector, we understand the importance of consistency and purity in drug synthesis. This benzonitrile derivative is engineered to facilitate efficient reaction pathways, minimizing byproduct formation and maximizing yield in downstream processes. The molecular structure, featuring methoxyethoxy side chains, provides specific reactivity profiles essential for constructing complex heterocyclic systems found in modern cancer therapeutics.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | 2-Amino-4,5-bis(2-methoxyethoxy)benzonitrile |
| CAS Number | 950596-58-4 |
| Molecular Formula | C13H18N2O4 |
| Molecular Weight | 266.29 g/mol |
| Appearance | Pale yellow powder |
| Purity (HPLC) | ≥98.0% |
| Moisture Content | ≤0.5% |
| Single Impurity | ≤1.0% |
Industrial Applications
The primary application of this chemical lies in the pharmaceutical sector, specifically within the supply chain for anticancer medications. It acts as a precursor molecule that undergoes further chemical transformations to achieve the final API structure. Due to its specific substitution pattern, it is highly valued for its ability to integrate seamlessly into complex synthetic routes. Beyond Erlotinib production, similar benzonitrile structures are often explored in medicinal chemistry for developing new kinase inhibitors and targeted therapies.
Researchers and procurement managers in the pharmaceutical industry rely on this intermediate for its reliability and performance. The high purity level ensures that subsequent reaction steps are not compromised by unforeseen side reactions, which is crucial for maintaining regulatory compliance in drug manufacturing. Our product supports both pilot-scale research and large-scale commercial production needs.
Quality Assurance and Packaging
We maintain a robust quality management system to guarantee the integrity of our chemicals. Each production lot undergoes rigorous testing using high-performance liquid chromatography (HPLC) and other analytical methods to verify identity and purity. Customers receive a comprehensive Certificate of Analysis (COA) with every shipment, detailing all test results against specifications.
- Standard packaging includes 25 kg drums lined with protective materials.
- Custom packaging solutions are available upon request to suit specific logistics requirements.
- Strict contamination control measures are implemented during filling and sealing.
- Global shipping capabilities ensure timely delivery to manufacturing sites worldwide.
Storage and Handling
To maintain optimal stability, this product should be stored in a cool, well-ventilated area away from direct sunlight and moisture. The container must remain tightly closed when not in use to prevent hydration or degradation. Handling should be conducted in accordance with standard laboratory safety protocols, including the use of appropriate personal protective equipment (PPE). Proper storage conditions ensure the material retains its specified properties throughout its shelf life, supporting consistent manufacturing outcomes.
